Whether the lung is a primary site of platelet (PLT) production is still disputed. To address this question, PLT parameters in blood before and after pulmonary circulation in humans, rats, and rabbits were assessed by automatic hematology analyzers; bone marrow and pulmonary megakaryocytes in humans, mice, rats, and rabbits were evaluated by immunohistochemical staining; and pulmonary megakaryocytes in humans were analyzed by single-cell RNA sequencing. We found that the mean number of PLTs in rats was nearly threefold greater than that in rabbits and humans. The PLT distribution width after pulmonary circulation in humans, rats, and rabbits was consistently less than that before pulmonary circulation. However, except for the PLT population in the left atrium of rats was significantly greater than that in the right ventricle (n=20), the PLT populations between the left and right atria of rats (n=19), rabbits (n=19), and humans (n=24), between the left atrium and right ventricle of rabbits (n=19), and between the inferior vena cava and radial artery of humans (n=93) had no differences. Moreover, megakaryocytes in the lungs of mice, rats, rabbits, and humans were mononuclear, were mainly located perivascularly, and accounted for approximately 3-5 ‰. Their numbers were significantly lower, and their sizes were smaller than those of bone marrow. Conclusively, the lung can produce PLTs, but it is not a primary site of PLT biogenesis. The capability of pulmonary PLT generation differs among species; at least in rats, it is greater than that in rabbits and humans.

Department of Anesthesia The 2nd Affiliated Hospital of Chongqing Medical University Chongqing China

Zobrazit více v PubMed

Machlus KR, Italiano JE., Jr The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013;201:785–796. doi: 10.1083/jcb.201304054. PubMed DOI PMC

Borges I, Sena I, Azevedo P, Andreotti J, Almeida V, Paiva A, Santos G, Guerra D, Prazeres P, Mesquita LL, Silva LSB, Leonel C, Mintz A, Birbrair A. Lung as a Niche for Hematopoietic Progenitors. Stem Cell Rev Rep. 2017;13:567–574. doi: 10.1007/s12015-017-9747-z. PubMed DOI PMC

Petrus AT, Lighezan DL, Danila MD, Duicu OM, Sturza A, Muntean DM, Ionita I. Assessment of platelet respiration as emerging biomarker of disease. Physiol Res. 2019;68:347–363. doi: 10.33549/physiolres.934032. PubMed DOI

Levine RF, Eldor A, Shoff PK, Kirwin S, Tenza D, Cramer EM. Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol. 1993;51:233–246. doi: 10.1111/j.1600-0609.1993.tb00637.x. PubMed DOI

Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, Krummel MF, Leavitt AD, Passegué E, Looney MR. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105–109. doi: 10.1038/nature21706. PubMed DOI PMC

Howell WH, Donahue DD. The production of blood platelets in the lungs. J Exp Med. 1937;65:177–203. doi: 10.1084/jem.65.2.177. PubMed DOI PMC

Kallinikos-Maniatis A. Megakaryocytes and platelets in central venous and arterial blood. Acta Haematol. 1969;42:330–335. doi: 10.1159/000208817. PubMed DOI

Pedersen NT. The pulmonary vessels as a filter for circulating megakaryocytes in rats. Scand J Haematol. 1974;13:225–231. doi: 10.1111/j.1600-0609.1974.tb00263.x. PubMed DOI

Pedersen NT. Occurrence of megakaryocytes in various vessels and their retention in the pulmonary capillaries in man. Scand J Haematol. 1978;21:369–375. doi: 10.1111/j.1600-0609.1978.tb00381.x. PubMed DOI

Boccatonda A, D’Ardes D, Rossi I, Grignaschi A, Lanotte A, Cipollone F, Guagnano MT, Giostra F. Platelet Count in Patients with SARS-CoV-2 Infection: A Prognostic Factor in COVID-19. J Clin Med. 2022;11:4112. doi: 10.3390/jcm11144112. PubMed DOI PMC

Wang T, Liu Z, Wang Z, Duan M, Li G, Wang S, Li W, Zhu Z, Wei Y, Christiani DC, Li A, Zhu X. Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PloS one. 2014;9:e94124. doi: 10.1371/journal.pone.0094124. PubMed DOI PMC

Giannakeas V, Kotsopoulos J, Cheung MC, Rosella L, Brooks JD, Lipscombe L, Akbari MR, Austin PC, Narod SA. Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period. JAMA Netw Open. 2022;5:e2141633. doi: 10.1001/jamanetworkopen.2021.41633. PubMed DOI PMC

Zhu Y, Wei Y, Zhang R, Dong X, Shen S, Zhao Y, Bai J, Albanes D, Caporaso NE, Landi MT, Zhu B, Chanock SJ, Gu F, Lam S, Tsao MS, Shepherd FA, Tardon A, Fernández-Somoano A, Fernandez-Tardon G, Chen C, Barnett MJ, Doherty J, Bojesen SE, Johansson M, Brennan P, McKay JD, Carreras-Torres R, Muley T, Risch A, Wichmann HE, Bickeboeller H, Rosenberger A, Rennert G, Saliba W, Arnold SM, Field JK, Davies MPA, Marcus MW, Wu X, Ye Y, Le Marchand L, Wilkens LR, Melander O, Manjer J, Brunnström H, Hung RJ, Liu G, Brhane Y, Kachuri L, Andrew AS, Duell EJ, Kiemeney LA, van der Heijden EH, Haugen A, Zienolddiny S, Skaug V, Grankvist K, Johansson M, Woll PJ, Cox A, Taylor F, Teare DM, Lazarus P, Schabath MB, Aldrich MC, Houlston RS, McLaughlin J, Stevens VL, Shen H, Hu Z, Dai J, Amos CI, Han Y, Zhu D, Goodman GE, Chen F, Christiani DC. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019;28:935–942. doi: 10.1158/1055-9965.EPI-18-0356. PubMed DOI PMC

Sylman JL, Boyce HB, Mitrugno A, Tormoen GW, Thomas IC, Wagner TH, Lee JS, Leppert JT, McCarty OJT, Mallick P. A Temporal Examination of Platelet Counts as a Predictor of Prognosis in Lung, Prostate, and Colon Cancer Patients. Sci Rep. 2018;8:6564. doi: 10.1038/s41598-018-25019-1. PubMed DOI PMC

Ji Y, Sheng L, Du X, Qiu G, Su D. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients. Platelets. 2015;26:138–142. doi: 10.3109/09537104.2014.888547. PubMed DOI

Pedersen LM, Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep. 2003;10:213–216. doi: 10.3892/or.10.1.213. PubMed DOI

Aliberti G, Proietta M, Pulignano I, Tritapepe L, Di Giovanni C, Schiappoli A, Vercillo G. The lungs and platelet production. Clin Lab Haematol. 2002;24:161–164. doi: 10.1046/j.1365-2257.2002.00375.x. PubMed DOI

Johnson CA, Human DG, Sacks RT, Mills AE. Circulating megakaryocytes and platelet production in children with congenital cardiac defects undergoing cardiac catheterisation. S Afr Med J. 1988;73:578–580. PubMed

Mei Y, Tang Z, Li Z, Yang X. Repeatability and Reproducibility of Quantitative Corneal Shape Analysis after Orthokeratology Treatment Using Image-Pro Plus Software. Journal of ophthalmology. 2016;2016:1732476. doi: 10.1155/2016/1732476. PubMed DOI PMC

Travaglini KJ, Nabhan AN, Penland L, Sinha R, Gillich A, Sit RV, Chang S, Conley SD, Mori Y, Seita J, Berry GJ, Shrager JB, Metzger RJ, Kuo CS, Neff N, Weissman IL, Quake SR, Krasnow MA. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020;587:619–625. doi: 10.1038/s41586-020-2922-4. PubMed DOI PMC

Slater DN, Trowbridge EA, Martin JF. The megakaryocyte in thrombocytopenia: a microscopic study which supports the theory that platelets are produced in the pulmonary circulation. Thromb Res. 1983;31:163–176. doi: 10.1016/0049-3848(83)90017-8. PubMed DOI

Chen SY, Du J, Lu XN, Xu JH. Platelet distribution width as a novel indicator of disease activity in systemic lupus erythematosus. J Res Med Sci. 2018;23:48. doi: 10.4103/jrms.JRMS_1038_16. PubMed DOI PMC

Kammers K, Taub MA, Mathias RA, Yanek LR, Kanchan K, Venkatraman V, Sundararaman N, Martin J, Liu S, Hoyle D, Raedschelders K, Holewinski R, Parker S, Dardov V, Faraday N, Becker DM, Cheng L, Wang ZZ, Leek JT, Van Eyk JE, Becker LC. Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells. J Thromb Haemost. 2021;19:1783–1799. doi: 10.1111/jth.15334. PubMed DOI

Dejima H, Nakanishi H, Kuroda H, Yoshimura M, Sakakura N, Ueda N, Ohta Y, Tanaka R, Mori S, Yoshida T, Hida T, Sawabata N, Yatabe Y, Sakao Y. Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. Lung cancer. 2018;125:128–135. doi: 10.1016/j.lungcan.2018.09.011. PubMed DOI

Potts KS, Farley A, Dawson CA, Rimes J, Biben C, de Graaf C, Potts MA, Stonehouse OJ, Carmagnac A, Gangatirkar P, Josefsson EC, Anttila C, Amann-Zalcenstein D, Naik S, Alexander WS, Hilton DJ, Hawkins ED, Taoudi S. Membrane budding is a major mechanism of in vivo platelet biogenesis. The Journal of experimental medicine. 2020;217:e20191206. doi: 10.1084/jem.20191206. PubMed DOI PMC

Yeung AK, Villacorta-Martin C, Hon S, Rock JR, Murphy GJ. Lung megakaryocytes display distinct transcriptional and phenotypic properties. Blood Adv. 2020;4:6204–6217. doi: 10.1182/bloodadvances.2020002843. PubMed DOI PMC

Shah B, Sedlis SP, Mai X, Amoroso NS, Guo Y, Lorin JD, Berger JS. Comparison of platelet activity measurements by use of arterial and venous blood sampling. J Thromb Haemost. 2013;11:1922–1924. doi: 10.1111/jth.12370. PubMed DOI PMC

Livada AC, Pariser DN, Morrell CN. Megakaryocytes in the lung: History and future perspectives. Res Pract Thromb Haemost. 2023;7:100053. doi: 10.1016/j.rpth.2023.100053. PubMed DOI PMC

Asquith NL, Carminita E, Camacho V, Rodriguez-Romera A, Stegner D, Freire D, Becker IC, Machlus KR, Khan A, Italiano JE., Jr The bone marrow is the primary site of thrombopoiesis. Blood. 2024;143:272–278. doi: 10.1182/blood.2023020895. PubMed DOI PMC